Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Hermansen_2007_Diabetes.Obes.Metab_9_733

Reference

Title: Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P
Ref: Diabetes Obes Metab, 9:733, 2007 : PubMed

        



Related information

Inhibitor | Sitagliptin,


Citations formats

Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P (2007)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
Diabetes Obes Metab 9: 733-45

Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P (2007)
Diabetes Obes Metab 9: 733-45



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer